# NexImmune Inc. (NEXI)

Source: https://www.quantisnow.com/company/NEXI
Generated: 2026-11-15T18:50:38.720Z

- Ticker: NEXI
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2021
- Website: neximmune.com

## About

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; and NEXI-002, an autologous cell therapy, which is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

## Latest NEXI news and filings

- 2024-09-06 11:41 UTC [SEC Form 25-NSE filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-neximmune-inc-5685289)
- 2024-08-29 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-neximmune-inc-5675639)
- 2024-08-27 20:10 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-neximmune-inc-5673384)
- 2024-08-27 20:08 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-neximmune-inc-5673351)
- 2024-08-27 20:06 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-neximmune-inc-5673333)
- 2024-08-27 20:03 UTC [SEC Form POS AM filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-neximmune-inc-5673261)
- 2024-08-27 20:01 UTC [SEC Form 8-K] [SEC Form 8-K filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-neximmune-inc-5673249)
- 2024-08-15 20:02 UTC [SEC Form 8-K] [SEC Form 8-K filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-neximmune-inc-5661181)
- 2024-08-07 20:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-neximmune-inc-5647387)
- 2024-08-02 20:05 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-neximmune-inc-5640231)
- 2024-08-02 20:03 UTC [SEC Form 8-K] [NexImmune Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/neximmune-inc-filed-sec-form-8-k-other-events-5640174)
- 2024-07-19 20:03 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-neximmune-inc-5617811)
- 2024-07-19 20:01 UTC [SEC Form 8-K] [NexImmune Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/neximmune-inc-filed-sec-form-8-k-other-events-5617790)
- 2024-07-11 19:12 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-neximmune-inc-5604319)
- 2024-07-11 19:10 UTC [SEC Form 8-K] [NexImmune Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/neximmune-inc-filed-sec-form-8-k-other-events-5604316)
- 2024-07-11 15:45 UTC [Market Chatter] [NexImmune Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 111%](https://www.quantisnow.com/insight/neximmune-shares-resume-trade-following-circuit-breaker-halt-stock-now-5603960)
- 2024-06-21 11:30 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-neximmune-inc-5569988)
- 2024-06-13 23:58 UTC [Insider Buy] [President and CEO Jones Kristi bought $0 worth of Series A Preferred Stock (1 units at $0.01) (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-jones-kristi-bought-0-worth-of-series-5557385)
- 2024-06-11 21:17 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-neximmune-inc-5551878)
- 2024-06-11 20:28 UTC [SEC Form 8-K] [NexImmune Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/neximmune-inc-filed-sec-form-8-k-unregistered-sales-of-equity-5551455)
- 2024-05-22 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-after-market-session-5510761)
- 2024-05-20 21:10 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-neximmune-inc-5504859)
- 2024-05-16 12:06 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-pre-market-session-5495642)
- 2024-05-15 20:01 UTC [SEC Form NT 10-Q filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-neximmune-inc-5493017)
- 2024-04-16 20:07 UTC [SEC Form 10-K] [SEC Form 10-K filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-neximmune-inc-5413285)
- 2024-04-10 21:13 UTC [SEC Form 3] [SEC Form 3 filed by new insider Marchio Albert N Ii](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-marchio-albert-n-5403987)
- 2024-04-05 20:11 UTC [Market Chatter] [NexImmune Inc: Appointed Albert N. Marchio II As Interim CFO](https://www.quantisnow.com/insight/neximmune-inc-appointed-albert-n-marchio-ii-as-interim-cfo-5395298)
- 2024-04-05 20:06 UTC [SEC Form 8-K] [SEC Form 8-K filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-neximmune-inc-5395242)
- 2024-03-29 20:05 UTC [SEC Form NT 10-K filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-neximmune-inc-5377793)
- 2024-03-07 18:35 UTC [Market Insight] [Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/why-highpeak-energy-shares-are-trading-lower-by-15-here-5326463)
- 2024-02-20 16:38 UTC [Market Chatter] [NexImmune Has Received A Decision To Grant European Patent Number EP3970748 Titled "Nanoparticle Compositions And Methods For Immunotherapy"](https://www.quantisnow.com/insight/neximmune-has-received-a-decision-to-grant-european-patent-number-5274331)
- 2024-02-19 21:30 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-after-market-session-5272567)
- 2024-02-06 21:42 UTC [Public Offering] [NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules](https://www.quantisnow.com/insight/neximmune-announces-closing-of-367-million-registered-direct-offering-priced-5234492)
- 2024-02-06 21:30 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-neximmune-inc-5234335)
- 2024-02-05 22:10 UTC [SEC Form 8-K] [NexImmune Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events](https://www.quantisnow.com/insight/neximmune-inc-filed-sec-form-8-k-entry-into-a-material-5230786)
- 2024-02-05 21:34 UTC [SEC Form 424B5] [SEC Form 424B5 filed by NexImmune Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-neximmune-inc-5230502)
- 2024-02-05 17:56 UTC [Market Insight] [Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session](https://www.quantisnow.com/insight/why-air-products-and-chemicals-shares-are-trading-lower-by-5229455)
- 2024-02-05 13:04 UTC [Market Insight] [Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-4d-molecular-therapeutics-shares-are-trading-higher-by-20-5228585)
- 2024-02-02 19:02 UTC [Market Chatter] [NexImmune Announces $3.67M Registered Direct Offering Of 304,731 Shares At $12.05/Share](https://www.quantisnow.com/insight/neximmune-announces-367m-registered-direct-offering-of-304731-shares-at-5226041)
- 2024-02-02 19:00 UTC [Public Offering] [NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules](https://www.quantisnow.com/insight/neximmune-announces-367-million-registered-direct-offering-priced-at-the-market-under-5226022)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/NEXI
- Earnings history: https://www.quantisnow.com/earnings/NEXI
- Dividend history: https://www.quantisnow.com/dividends/NEXI
- Insider transactions: https://www.quantisnow.com/insiders/NEXI
- Options chain: https://www.quantisnow.com/options/NEXI
- SEC 8-K filings only: https://www.quantisnow.com/company/NEXI/8-k
- RSS and alerts for NEXI: https://www.quantisnow.com/docs/rss-feeds.md